Colchicine poisoning is rare but can cause potentially life-threatening toxic complications such as hypovolemic shock, cardiovascular collapse and multiple organ failure. In this case report, we describe a case of a 20-year-old female who presented to the emergency department after suicidal ingestion of a toxic dose of colchicine. She developed thrombocytopenia, neutropenia and acute respiratory distress syndrome that required blood transfusion and administration of granulocyte colony stimulating factor for the prevention of infectious complications. With regard to the clinical manifestations of colchicine toxicity, we discussed suggested mechanisms.
After that, ANC increased gradually and additional lenograstim was not given (Fig. 1) . However, FFP and platelets were transfused until platelet and PT INR levels did not de- crease without transfusion ( 
Discussion
Acute toxic manifestations of colchicine poisoning can be divided broadly into four stages. Bone marrow suppression is a predominant finding in stage 3, which occurs on days 3 to 6 post-exposure and continues for 7 to 10 days. [3] Prior to bone marrow suppression, gastrointestinal symptoms with volume depletion and multi-organ dysfunction may develop in stages 1 and 2, which begin 2 to 8 hours and 24 hours after ingestion, respectively. In stage 4, which begins 7 days after ingestion, generalized alopecia and rebound leukocytosis can be observed.
The ingestion of a toxic dose of colchicine, which ranges The main treatment of colchicine intoxication is supportive. If the patient presents to a hospital within 1-2 hours of ingestion, the physician can perform gastric lavage and administer activated charcoal. [8] If a large amount of colchicine ingestion is suspected, multiple-dose activated charcoal can be considered because colchicine has enterohepatic recirculation. [9] In the early stage of colchicine intoxication, fluid resuscitation is important because acute renal injury can develop due to severe hypovolemia and muscle injury. Coagulation disorder and neutropenia should be managed with blood product transfusions and granulocyte colony-stimulating factor (G-CSF) administration. There are a few reported cases in which G-CSF was used in the treatment of colchicine poisoning. [3, [10] [11] [12] [13] [14] In these cases, G-CSF was suggested as supportive therapy for leukopenia because it shortened the duration of neutropenia and could help prevent the development of septicemia by accelerating the production of neutrophils within the bone marrow. Broad-spectrum antibiotics should also be considered if there are clinical signs suggestive of infection. In our patient, neutropenia recovered after a single dose of G-CSF. However, there are cases in which G-CSF was given for several days for neutropenia, [3, 10] and patient outcome was poor despite G-CSF administration. [12] [13] [14] In one case of colchicine poisoning, treatment with colchicine-specific Fab fragment antibodies was effective. [15] The efficacy was explained by the high affinity of colchicinespecific antibodies to colchicine, which immunoneutralized the effects of colchicine. However, these fragments are not available in clinical practice.
We assumed that clinical features in our patient were typical and, fortunately, less severe than expected considering the amount of colchicine ingested. Her young age and good response to treatment also seemed to contribute to her recovery without major complications.
In conclusion, colchicine poisoning can lead to life-threatening multi-organ damage, and there are no therapeutic methods to eliminate colchicine. Thus, aggressive supportive care should be performed from the time of presentation to prevent progression to multi-organ failure.
